KUALA LUMPUR: Hovid’s new tablet and capsule plant is set to start operating by mid-2015 which will remove the capacity constraints.
CIMB Equities Research said on Thursday the new plant may raise Hovid’s depreciation charges by about RM1mil annually, which is slightly higher than its expectation.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!